On the basis of these observations, we hypothesized that MTs in the coding region of NRF2 might cause aberrant transcriptional activity and have some effect on MMP9 transactivation when BRAF MT is also present in liver cancer cells. This evidence concerns the gene NFE2L2 and liver cancer.